All In Biotech

Free tool

FAERS Monitor: Fycompa

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208277 or its brand name (Fycompa, Perampanel). Reports on generic versions are filed under their own applications.

Reports

7,728

Serious

6,392

83% of reports

Hospitalization

2,965

Death reported

472

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • seizure1,171
  • drug ineffective1,129
  • off label use830
  • somnolence525
  • aggression504
  • dizziness408
  • epilepsy377
  • status epilepticus350
  • drug interaction343
  • multiple-drug resistance332
  • fatigue316
  • irritability253
  • condition aggravated247
  • fall244
  • gait disturbance226

Reports by year received

View as table
YearReports
20128
201316
2014183
2015275
2016332
2017455
2018572
2019705
2020664
2021779
2022668
2023765
2024908
2025884
2026514

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,431 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
multiple-drug resistanceSignal332326.2291.795,841
status epilepticusSignal35087.078.428,776
epilepsySignal37734.030.811,899
seizureSignal1,17127.926.430,161
aggressionSignal50427.725.412,833
irritabilitySignal25311.510.22,411
somnolenceSignal5257.16.52,771
drug interactionSignal3435.95.31,397
gait disturbanceSignal2263.22.8346
off label useSignal8302.62.4837
drug ineffectiveSignal1,1292.32.2915
dizzinessSignal4082.22.0281
condition aggravatedSignal2472.22.0165
fall2442.01.8122
fatigue3161.11.03

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.